Developer docs
API playgroundTry for free, no card

Search company profiles

Intrasense

Full company profile

uuid00064l2

Namestring
Intrasense
Legal namestring
INTRASENSE
Websiteurl
intrasense.fr
Company typeenum
Public
Founded yearint
2004
Descriptiontext

Intrasense is a French medical imaging software company founded in 2004 and headquartered in Montpellier, France, listed on Euronext Growth Paris (ticker ALINS) and operating as a subsidiary of Guerbet, the global medical imaging leader. The company designs, develops, and commercializes the Myrian platform, a multi-modality visualization and analysis environment supporting MRI, CT, mammography, tomosynthesis, and ultrasound imaging, along with a portfolio of specialized clinical applications organized by anatomy and pathology (e.g., Myrian XP-Prostate, XP-Lung, XP-Liver, XP-Breast, XP-Female Pelvis, XP-Cardio, XP-Colon, XP-AbdoFat, XP-Oncology).

The company's AI capability is anchored in proprietary lesion detection algorithms deployed as DUOnco Liver, DUOnco Bone, and DUOnco Pancreas modules and as add-on AI options for Myrian XP-Prostate (PI-CAI Challenge-winning algorithm) and Myrian XP-LungNodule (92.4% sensitivity). Liflow provides automated oncology follow-up with lesion tracking and therapeutic response assessment. All Class II products hold CE marking under MDR 745/2017, and DUOnco Pancreas additionally holds FDA Breakthrough Device designation and PMDA certification in Japan.

Intrasense commercializes primarily through a direct enterprise sales motion targeting hospital radiology departments, oncology centers, and imaging centers on a quote-based subscription/one-time-license model, supplemented by Guerbet's global distribution channel, an AI Hub that integrates third-party imaging AI (Nurea, Milvue, Icometrix ico*brain), and participation in major radiology congresses (JFR, RSNA, ECR, SIRM, SERAM, RöKö, AFIB). Reported FY2025 revenue is €3.2 million (+43% YoY) across 1,200+ clients worldwide, with ~70 employees based in Montpellier.

Short descriptiontext

Intrasense is a French medical imaging software company that develops the Myrian multi-modality visualization platform and proprietary AI lesion detection modules (DUOnco, Liflow) for hospital radiology and oncology departments worldwide. It operates as a subsidiary of Guerbet.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMontpellier, France
HQ citystring
Montpellier
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical imaging software, radiology visualization platform, AI lesion detection, oncology follow-up software, clinical decision support
Industry2 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Medical Equipment and Supplies Manufacturing3391
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Imaging Software Licensing
TypeSubscription Recurring
Description

Sale of medical device software including Myrian platform, DUOnco suite, and Liflow application. Products are Class II medical devices with CE marking under MDR 745/2017, sold to healthcare professionals and institutions.

intrasense.fr
2Software Licenses and Updates
TypeOne Time License
Description

Revenue generated from software licenses, version updates (Myrian 2.14), and ongoing product support for the Myrian visualization platform and specialized clinical applications.

intrasense.fr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise licensing for healthcare institutions
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing for hospitals and radiology departments. Products are medical devices classified as Class II under MDR 745/2017.

intrasense.fr
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Myrian
Description

Advanced multi-modality visualization platform for medical imaging analysis, processing, and management.

intrasense.fr
+2 more records
Core offering1 text field

Intrasense designs and develops Class II medical device software for AI-enhanced medical imaging, centered on the Myrian® multi-modality visualization platform supporting MRI, CT, mammography, tomosynthesis, and ultrasound. The portfolio includes the DUOnco™ family of AI lesion detection modules (Liver, Bone, Pancreas) and the Liflow® automated oncology follow-up application, all sold to radiology departments, oncology centers, and hospitals worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 92.4% sensitivity for lung nodule detection including ground-glass nodules
+2 more records
Product overview1 text field

Intrasense offers a unified medical imaging software ecosystem centered on the Myrian® platform, a multi-modality visualization and analysis platform supporting MRI, CT, mammography, tomosynthesis, and ultrasound imaging. The portfolio includes specialized clinical applications organized by anatomy and pathology: Myrian XP-Prostate with optional AI, Myrian XP-Lung/LungNodule with optional AI, Myrian XP-Oncology/Liver/Colon/AbdoFat for abdominal imaging, Myrian XP-Breast/XM-MG/XP-Female Pelvis for women's health, and Myrian XP-Cardio for cardiovascular imaging. AI-enhanced offerings include the DUOnco™ family (Liver, Bone, Pancreas) for automated lesion detection, and Liflow® for automated oncology follow-up. The company also distributes Icometrix's ico**brain** brain imaging solutions and integrates third-party AI through its AI Hub (Nurea, Milvue).

Product and service8 records
1Myrian® Platform
CategoryMedical Imaging Visualization Platform
Description

Multi-modality medical imaging platform providing advanced visualization, processing, and analysis of MRI, CT, mammography, tomosynthesis, and ultrasound images. It is the core platform hosting clinical applications and AI solutions for radiology workflows, sold to hospitals and radiology departments.

2DUOnco™ Pancreas
CategoryAI Oncology Lesion Detection
Description

Software for automatic detection and measurement of pancreatic focal lesions and main pancreatic duct in contrast CT images. Class II medical device with CE marking, FDA Breakthrough Device designation, and PMDA certification in Japan, intended for oncology and radiology specialists.

3DUOnco™ Liver
CategoryAI Oncology Lesion Detection
Description

Software for automatic detection and measurement of hepatic lesions in contrast-enhanced CT images (portal phase). Class II medical device with CE marking, used by radiologists and oncologists.

4DUOnco™ Bone
CategoryAI Oncology Lesion Detection
Description

Software for automatic detection of bone lesions in CT images. Class II medical device with CE marking under MDR 745/2017, for radiology and oncology use.

5Liflow®
CategoryOncology Follow-up Software
Description

AI-enhanced application dedicated to automated oncology follow-up and interpretation of oncology examinations. Automates lesion tracking, therapeutic response assessment, and structured reporting for cancer patient monitoring, used by oncology specialists and radiologists.

6ico*brain (Icometrix)
CategoryBrain Imaging Analysis Software
Description

Brain imaging analysis solutions including ico*brain mr (MR brain structure labeling and volumetric quantification), ico*brain ct (CT brain structure analysis), and ico*brain ctp (CT perfusion analysis for cerebral blood flow and volume). Class IIa medical devices distributed by Intrasense through partnership with Icometrix.

7Myrian XP-Prostate Option AI
CategoryAI Prostate MRI Analysis
Description

AI option for Myrian XP-Prostate that analyzes multiparametric prostate MRI scans, automatically segments the prostate, calculates PSA density, and detects suspicious areas with PIRADS > 3. Used by urologists and radiologists specializing in prostate cancer diagnosis.

8Myrian XP-LungNodule Option AI
CategoryAI Lung Nodule Detection
Description

AI-powered lung nodule detection option with automatic detection of solid and sub-solid nodules, synchronized comparison of detected anomalies, and 92.4% sensitivity including ground-glass nodules. Used by chest and lung radiologists.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-08
Description

Guerbet is a global leader in medical imaging and the parent company of Intrasense. The partnership focuses on co-development and distribution of DUOnco AI products (Liver, Bone, Pancreas). Guerbet announced FDA Breakthrough Device designation for DUOnco Pancreas and holds PMDA certification for Japan market. Guerbet opened share capital to Guerbet group in 2022-2023.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with Montpellier Cancer Institute to validate and deploy the new oncology platform in real-life clinical situations with the objective of clinical routine use.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Vitrea (Canon Medical / Vital Images)
TypeDirect peer
Description

Vitrea is a multi-modality advanced visualization platform from Canon Medical that, like Myrian, provides specialty clinical applications (oncology, cardiac, neuro, vascular) on top of a workstation. It competes head-to-head with Myrian in radiology departments seeking best-of-breed visualization with embedded clinical workflows.

TypeBroad incumbent
Description

Philips IntelliSpace Portal is an enterprise multi-modality visualization and advanced analysis suite sold to large hospital systems. It overlaps with Myrian's multi-modality, multi-specialty positioning but is bundled into Philips' broader imaging hardware, PACS, and AI portfolio.

TypeBroad incumbent
Description

syngo.via is Siemens Healthineers' multi-modality reading and post-processing platform with embedded AI (AI-Rad Companion). It targets the same enterprise radiology buyer as Myrian but benefits from Siemens' installed imaging-modality base and global sales force.

TypeBroad incumbent
Description

GE HealthCare's AW Workstation and Edison AI platform provide multi-modality visualization and AI applications sold to hospitals alongside GE imaging equipment. Direct overlap with Intrasense's Myrian + DUOnco positioning, with greater scale and capital.

TypeDirect peer
Description

Aidoc is a clinical AI platform offering AI-powered detection and triage algorithms for radiology (CT, MR) integrated into PACS workflows. It is a direct competitor in AI lesion detection and workflow orchestration, with broader US market penetration and significant venture funding.

TypeDirect peer
Description

Lunit is a Korean medical AI company specializing in lesion detection in oncology (notably Lunit INSIGHT for chest and mammography). It competes with Intrasense's DUOnco and Myrian XP-LungNodule in AI-driven oncology imaging, with a similar CE-marked, multi-product approach.

TypeDirect peer
Description

Icometrix (maker of ico*brain) is a brain imaging AI company whose products are actually distributed by Intrasense. Beyond this partnership, Icometrix competes directly in specialty clinical AI modules similar to Intrasense's strategy of embedding high-value clinical apps within a broader platform.

TypeDirect peer
Description

Arterys, now part of Tempus, provides cloud-native AI-powered medical imaging workflows including oncology and cardiac analysis. It competes with Myrian in offering AI-augmented specialty viewers on a platform model.

TypeDirect peer
Description

Mirada Medical offers advanced visualization and AI-based image analysis software for oncology and radiology. It directly overlaps with Intrasense's specialty clinical modules (e.g., Myrian XP-Prostate, Myrian XP-Lung) and competes for similar hospital and OEM channels.

TypeBroad incumbent
Description

Carestream sells Vue PACS and clinical viewing/workflow software to hospitals worldwide. It is an incumbent in radiology IT with overlapping visualization and workflow functionality, though its AI capabilities are less developed than Intrasense's DUOnco suite.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Intrasense

Medical Imaging Softwareintrasense.fr

Intrasense is a French medical imaging software company that develops the Myrian multi-modality visualization platform and proprietary AI lesion detection modules (DUOnco, Liflow) for hospital radiology and oncology departments worldwide. It operates as a subsidiary of Guerbet.

What Intrasense does

Intrasense is a French medical imaging software company founded in 2004 and headquartered in Montpellier, France, listed on Euronext Growth Paris (ticker ALINS) and operating as a subsidiary of Guerbet, the global medical imaging leader. The company designs, develops, and commercializes the Myrian platform, a multi-modality visualization and analysis environment supporting MRI, CT, mammography, tomosynthesis, and ultrasound imaging, along with a portfolio of specialized clinical applications organized by anatomy and pathology (e.g., Myrian XP-Prostate, XP-Lung, XP-Liver, XP-Breast, XP-Female Pelvis, XP-Cardio, XP-Colon, XP-AbdoFat, XP-Oncology).

The company's AI capability is anchored in proprietary lesion detection algorithms deployed as DUOnco Liver, DUOnco Bone, and DUOnco Pancreas modules and as add-on AI options for Myrian XP-Prostate (PI-CAI Challenge-winning algorithm) and Myrian XP-LungNodule (92.4% sensitivity). Liflow provides automated oncology follow-up with lesion tracking and therapeutic response assessment. All Class II products hold CE marking under MDR 745/2017, and DUOnco Pancreas additionally holds FDA Breakthrough Device designation and PMDA certification in Japan.

Intrasense commercializes primarily through a direct enterprise sales motion targeting hospital radiology departments, oncology centers, and imaging centers on a quote-based subscription/one-time-license model, supplemented by Guerbet's global distribution channel, an AI Hub that integrates third-party imaging AI (Nurea, Milvue, Icometrix ico*brain), and participation in major radiology congresses (JFR, RSNA, ECR, SIRM, SERAM, RöKö, AFIB). Reported FY2025 revenue is €3.2 million (+43% YoY) across 1,200+ clients worldwide, with ~70 employees based in Montpellier.

Intrasense firmographics

Firmographics
Name
Intrasense
Legal name
INTRASENSE
Website
https://intrasense.fr
Company type
Public
Founded year
2004
Operating status
Operating
Headcount range
51–100 employees
Short description
Intrasense is a French medical imaging software company that develops the Myrian multi-modality visualization platform and proprietary AI lesion detection modules (DUOnco, Liflow) for hospital radiology and oncology departments worldwide. It operates as a subsidiary of Guerbet.
Ownership category
akta.pro rank

Intrasense industry classification

Industry
Product category
Medical Imaging Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI

Keywords

  • Medical imaging software
  • Radiology visualization platform
  • AI lesion detection
  • Oncology follow-up software
  • Clinical decision support

Where Intrasense is headquartered

Location

Headquarters

HQ city
Montpellier
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Intrasense business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Medical Imaging Software Licensing: Sale of medical device software including Myrian platform, DUOnco suite, and Liflow application. Products are Class II medical devices with CE marking under MDR 745/2017, sold to healthcare professionals and institutions.
  2. Software Licenses and Updates: Revenue generated from software licenses, version updates (Myrian 2.14), and ongoing product support for the Myrian visualization platform and specialized clinical applications.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise licensing for healthcare institutions

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Intrasense product offering

Product offering

Core offering

Intrasense designs and develops Class II medical device software for AI-enhanced medical imaging, centered on the Myrian® multi-modality visualization platform supporting MRI, CT, mammography, tomosynthesis, and ultrasound. The portfolio includes the DUOnco™ family of AI lesion detection modules (Liver, Bone, Pancreas) and the Liflow® automated oncology follow-up application, all sold to radiology departments, oncology centers, and hospitals worldwide.

Product overview

Intrasense offers a unified medical imaging software ecosystem centered on the Myrian® platform, a multi-modality visualization and analysis platform supporting MRI, CT, mammography, tomosynthesis, and ultrasound imaging. The portfolio includes specialized clinical applications organized by anatomy and pathology: Myrian XP-Prostate with optional AI, Myrian XP-Lung/LungNodule with optional AI, Myrian XP-Oncology/Liver/Colon/AbdoFat for abdominal imaging, Myrian XP-Breast/XM-MG/XP-Female Pelvis for women's health, and Myrian XP-Cardio for cardiovascular imaging. AI-enhanced offerings include the DUOnco™ family (Liver, Bone, Pancreas) for automated lesion detection, and Liflow® for automated oncology follow-up. The company also distributes Icometrix's ico**brain** brain imaging solutions and integrates third-party AI through its AI Hub (Nurea, Milvue).

Differentiator

Problem solved

Functional benefit

Brands

  • Myrian: Advanced multi-modality visualization platform for medical imaging analysis, processing, and management.
  • DUOnco
  • Liflow

Products and services

  • Myrian® Platform Multi-modality medical imaging platform providing advanced visualization, processing, and analysis of MRI, CT, mammography, tomosynthesis, and ultrasound images. It is the core platform hosting clinical applications and AI solutions for radiology workflows, sold to hospitals and radiology departments.
  • DUOnco™ Pancreas Software for automatic detection and measurement of pancreatic focal lesions and main pancreatic duct in contrast CT images. Class II medical device with CE marking, FDA Breakthrough Device designation, and PMDA certification in Japan, intended for oncology and radiology specialists.
  • DUOnco™ Liver Software for automatic detection and measurement of hepatic lesions in contrast-enhanced CT images (portal phase). Class II medical device with CE marking, used by radiologists and oncologists.
  • DUOnco™ Bone Software for automatic detection of bone lesions in CT images. Class II medical device with CE marking under MDR 745/2017, for radiology and oncology use.
  • Liflow® AI-enhanced application dedicated to automated oncology follow-up and interpretation of oncology examinations. Automates lesion tracking, therapeutic response assessment, and structured reporting for cancer patient monitoring, used by oncology specialists and radiologists.
  • ico*brain (Icometrix) Brain imaging analysis solutions including ico*brain mr (MR brain structure labeling and volumetric quantification), ico*brain ct (CT brain structure analysis), and ico*brain ctp (CT perfusion analysis for cerebral blood flow and volume). Class IIa medical devices distributed by Intrasense through partnership with Icometrix.
  • Myrian XP-Prostate Option AI AI option for Myrian XP-Prostate that analyzes multiparametric prostate MRI scans, automatically segments the prostate, calculates PSA density, and detects suspicious areas with PIRADS > 3. Used by urologists and radiologists specializing in prostate cancer diagnosis.
  • Myrian XP-LungNodule Option AI AI-powered lung nodule detection option with automatic detection of solid and sub-solid nodules, synchronized comparison of detected anomalies, and 92.4% sensitivity including ground-glass nodules. Used by chest and lung radiologists.

Quantifiable outcome

  • 92.4% sensitivity for lung nodule detection including ground-glass nodules
  • +2 more outcomes

Companies that use Intrasense

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Intrasense technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability4 records

Feature6 records

Intrasense partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • GuerbetcoreStrategic or Co-development Partner · 8 June 2026Guerbet is a global leader in medical imaging and the parent company of Intrasense. The partnership focuses on co-development and distribution of DUOnco AI products (Liver, Bone, Pancreas). Guerbet announced FDA Breakthrough Device designation for DUOnco Pancreas and holds PMDA certification for Japan market. Guerbet opened share capital to Guerbet group in 2022-2023.
  • ICM (Institut du Cancer de Montpellier)coreStrategic or Co-development PartnerPartnership with Montpellier Cancer Institute to validate and deploy the new oncology platform in real-life clinical situations with the objective of clinical routine use.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Intrasense competitors and assessment

Company assessment

Direct peers

  • Vitrea (Canon Medical / Vital Images): Vitrea is a multi-modality advanced visualization platform from Canon Medical that, like Myrian, provides specialty clinical applications (oncology, cardiac, neuro, vascular) on top of a workstation. It competes head-to-head with Myrian in radiology departments seeking best-of-breed visualization with embedded clinical workflows.
  • Aidoc: Aidoc is a clinical AI platform offering AI-powered detection and triage algorithms for radiology (CT, MR) integrated into PACS workflows. It is a direct competitor in AI lesion detection and workflow orchestration, with broader US market penetration and significant venture funding.
  • Lunit: Lunit is a Korean medical AI company specializing in lesion detection in oncology (notably Lunit INSIGHT for chest and mammography). It competes with Intrasense's DUOnco and Myrian XP-LungNodule in AI-driven oncology imaging, with a similar CE-marked, multi-product approach.
  • Icometrix: Icometrix (maker of ico*brain) is a brain imaging AI company whose products are actually distributed by Intrasense. Beyond this partnership, Icometrix competes directly in specialty clinical AI modules similar to Intrasense's strategy of embedding high-value clinical apps within a broader platform.
  • Arterys (Tempus): Arterys, now part of Tempus, provides cloud-native AI-powered medical imaging workflows including oncology and cardiac analysis. It competes with Myrian in offering AI-augmented specialty viewers on a platform model.
  • Mirada Medical: Mirada Medical offers advanced visualization and AI-based image analysis software for oncology and radiology. It directly overlaps with Intrasense's specialty clinical modules (e.g., Myrian XP-Prostate, Myrian XP-Lung) and competes for similar hospital and OEM channels.

Broad incumbents

  • Philips IntelliSpace Portal: Philips IntelliSpace Portal is an enterprise multi-modality visualization and advanced analysis suite sold to large hospital systems. It overlaps with Myrian's multi-modality, multi-specialty positioning but is bundled into Philips' broader imaging hardware, PACS, and AI portfolio.
  • Siemens Healthineers syngo.via: syngo.via is Siemens Healthineers' multi-modality reading and post-processing platform with embedded AI (AI-Rad Companion). It targets the same enterprise radiology buyer as Myrian but benefits from Siemens' installed imaging-modality base and global sales force.
  • GE HealthCare AW Workstation / Edison: GE HealthCare's AW Workstation and Edison AI platform provide multi-modality visualization and AI applications sold to hospitals alongside GE imaging equipment. Direct overlap with Intrasense's Myrian + DUOnco positioning, with greater scale and capital.
  • Carestream Health: Carestream sells Vue PACS and clinical viewing/workflow software to hospitals worldwide. It is an incumbent in radiology IT with overlapping visualization and workflow functionality, though its AI capabilities are less developed than Intrasense's DUOnco suite.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Intrasense social profiles

Digital presence

Intrasense compliance and trust

Trust signal

Compliance6 records

Intrasense financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Intrasense leadership team

Management profile

Number of profiles

Profiles5 records

Intrasense funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Intrasense M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intrasense

What does Intrasense do?

Intrasense designs and develops Class II medical device software for AI-enhanced medical imaging, centered on the Myrian® multi-modality visualization platform supporting MRI, CT, mammography, tomosynthesis, and ultrasound. The portfolio includes the DUOnco™ family of AI lesion detection modules (Liver, Bone, Pancreas) and the Liflow® automated oncology follow-up application, all sold to radiology departments, oncology centers, and hospitals worldwide.

Is Intrasense a public or private company?

Intrasense is a public company. It is classified as public and is currently operating.

When was Intrasense founded?

Intrasense was founded in 2004. It employs 51 to 100 people.

Where is Intrasense based?

Intrasense is headquartered in Montpellier, France, in the Europe region.

How does Intrasense make money?

Two revenue lines are on record. Medical Imaging Software Licensing is the primary driver. The others are software Licenses and Updates.

Who are Intrasense's main competitors?

Direct peers on record are Vitrea (Canon Medical / Vital Images), Aidoc, Lunit, Icometrix, Arterys (Tempus) and Mirada Medical. Broad incumbents are Philips IntelliSpace Portal, Siemens Healthineers syngo.via, GE HealthCare AW Workstation / Edison and Carestream Health.

Does Intrasense have an API?

No public API is recorded for Intrasense.

What industry is Intrasense in?

Intrasense's product category is Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals